| Product Code: ETC7333180 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Oncology-Cancer Drugs Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 Ghana Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 Ghana Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ghana Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Ghana Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ghana |
4.2.2 Improving healthcare infrastructure and facilities |
4.2.3 Growing awareness and adoption of oncology treatments |
4.3 Market Restraints |
4.3.1 High cost of cancer drugs |
4.3.2 Limited access to advanced oncology treatments |
4.3.3 Regulatory hurdles and approval processes |
5 Ghana Oncology-Cancer Drugs Market Trends |
6 Ghana Oncology-Cancer Drugs Market, By Types |
6.1 Ghana Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 Ghana Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 Ghana Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 Ghana Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Ghana Oncology-Cancer Drugs Market Export to Major Countries |
7.2 Ghana Oncology-Cancer Drugs Market Imports from Major Countries |
8 Ghana Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Patient survival rates |
8.2 Average age of cancer diagnosis |
8.3 Number of oncology clinical trials conducted |
8.4 Adoption rate of targeted therapies |
8.5 Availability and utilization of palliative care services |
9 Ghana Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 Ghana Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ghana Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Ghana Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 Ghana Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ghana Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here